ROHTO PHARMACEUTICAL CO.,LTD. 4527Short Interest
No institution currently reports a short position of 0.5% or more in ROHTO PHARMACEUTICAL CO.,LTD. (4527). The last disclosure was on 2026-11-16 (Morgan Stanley MUFG Securities Co., Ltd., 0.46%).
Estimated short interest
0.00%
±0.00%
Estimated position (shares)
0
As of 2026-11-18
Holders (0.5% or more)
0 firms
13 reports
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It excludes 1 institutions whose last report is more than a year old (7.32% in total). It also excludes 4 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2022-10-21 |
|---|---|
| Latest disclosure | 2026-11-16 (Morgan Stanley MUFG Securities Co., Ltd., 0.46%) |
| Reporting institutions | 5 firms (13 reports) |
| Peak estimated short interest | 7.87% (2025-09-16, 2 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 5 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- BNP Paribas Financial Markets SNC
- Barclays Bank PLC
- Morgan Stanley MUFG Securities Co., Ltd.
- Integrated Core Strategies (Asia) Pte. Ltd.
- MERRILL LYNCH INTERNATIONAL
0.00%
Estimated short interest, 2026-11-18
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2025-08-12 | BNP Paribas Financial Markets SNC | Position 173 shares | Ratio 7.32% | ▲7.09% | No report for 1+ year |
| 2026-11-16 | Morgan Stanley MUFG Securities Co., Ltd. | Position 1,099,586 shares | Ratio 0.46% | ▼0.06% | Below 0.5% |
| 2025-10-01 | Barclays Bank PLC | Position 887,638 shares | Ratio 0.37% | ▼0.18% | Below 0.5% |
| 2025-01-06 | MERRILL LYNCH INTERNATIONAL | Position 308,760 shares | Ratio 0.13% | ▼0.37% | Below 0.5% |
| 2022-10-28 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 92,760 shares | Ratio 0.07% | ▼0.43% | Below 0.5% |
Disclosure History 13 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2026-11-16 | Morgan Stanley MUFG Securities Co., Ltd. | Position 1,099,586 shares | Ratio 0.46% | ▼0.06% | Below 0.5% |
| 2026-11-09 | Morgan Stanley MUFG Securities Co., Ltd. | Position 1,239,695 shares | Ratio 0.52% | ▲0.04% | — |
| 2026-10-26 | Morgan Stanley MUFG Securities Co., Ltd. | Position 1,154,551 shares | Ratio 0.48% | ▼0.02% | Below 0.5% |
| 2026-10-19 | Morgan Stanley MUFG Securities Co., Ltd. | Position 1,200,118 shares | Ratio 0.50% | ▲0.06% | — |
| 2025-10-01 | Barclays Bank PLC | Position 887,638 shares | Ratio 0.37% | ▼0.18% | Below 0.5% |
| 2025-09-16 | Barclays Bank PLC | Position 1,317,574 shares | Ratio 0.55% | ▲0.17% | — |
| 2025-08-12 | BNP Paribas Financial Markets SNC | Position 173 shares | Ratio 7.32% | ▲7.09% | — |
| 2025-08-05 | BNP Paribas Financial Markets SNC | Position 1,149,673 shares | Ratio 0.48% | ▼0.03% | Below 0.5% |
| 2025-08-01 | BNP Paribas Financial Markets SNC | Position 1,212,073 shares | Ratio 0.51% | ▲0.11% | — |
| 2025-01-06 | MERRILL LYNCH INTERNATIONAL | Position 308,760 shares | Ratio 0.13% | ▼0.37% | Below 0.5% |
| 2024-12-30 | MERRILL LYNCH INTERNATIONAL | Position 1,202,019 shares | Ratio 0.50% | ▲0.50% | — |
| 2022-10-28 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 92,760 shares | Ratio 0.07% | ▼0.43% | Below 0.5% |
| 2022-10-21 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 599,239 shares | Ratio 0.50% | ▲0.09% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |